Professional background

I built two #1 franchises that dominated UK life sciences investment banking for over ten years. I helped advise, finance, and build some of the most successful public and private companies in the sector, with several £1bn+ successes, including Oxford Nanopore, Abcam, Syncona, Oxford Sciences, Exscientia, Clinigen, Vectura, PureTech, The Binding Site and IP Group. I have worked with many other life sciences companies also, and with many talented entrepreneurs, executives, investors and advisors during my time in the city.

Fachgebiete

As a top-ranked life sciences analyst from the early 2000s through to 2022, I have a strong track record of identifying companies with promising technologies or business models at a relatively early stage and working with them across their lifecycle.